Joseph Femino, MD

Associate Professor of Clinical Orthopaedic Surgery

Chief of Musculoskeletal Oncology

Image of Joseph Femino, MD
Is this your profile? Click to edit

Overview

Dr. Femino is a nationally renowned musculoskeletal oncologist . Dr. Femino is a honors graduate of Yale University. He received his MD degree from Johns Hopkins University School of Medicine and he completed his orthopaedic residency training at Johns Hopkins Hospital. After residency, Dr. Femino actually completed two fellowships. He did an orthopaedic oncology fellowship at the University of Washington followed by a pediatric orthopaedic surgery fellowship at Children’s Hospital Los Angeles. After completing his fellowship, Dr. Femino was on staff at CHLA for a number of years before moving to City of Hope in 2007. He joined USC in 2024 as Chief of Musculoskeletal Oncology.

Dr. Femino is one of the most experienced musculoskeletal oncologists in Southern California. As Chief of the service line, he will mentor and oversee the other orthopaedic oncologists in the department. He will also work in conjunction with the medical oncologists at Norris Cancer Center to develop multidisciplinary clinical and research programs.

Publications

  • Long-Term Follow-up of High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Children and Young Adults with Metastatic or Relapsed Ewing Sarcoma: A Single-Institution ExperienceTransplant Cell Ther. 2021 01; 27(1):72. e1-72. e7. . View in PubMed
  • Outpatient Opioid Prescribing Habits in Pediatric Patients With Bone Sarcomas After Undergoing Primary Tumor Resection J Pediatr Orthop. 2022 May-Jun 01; 42(5):e501-e506. . View in PubMed
  • All-Internal Limb Lengthening with Simultaneous Corrective Osteotomy After Internal Hemipelvectomy: A Case Report JBJS Case Connect. 2022 04 01; 12(2). . View in PubMed
  • Robotic assistance for quick and accurate image-guided needle placement Updates Surg. 2021 Jun; 73(3):1197-1201. . View in PubMed
  • Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children’s Oncology Group Pediatr Blood Cancer. 2016 Mar; 63(3):493-8. . View in PubMed